BioRestorative Therapies, Inc. SEC filings BRTX
BioRestorative Therapies, Inc. has 754 filings in SEC EDGAR's recent list, going back to Nov 16, 2010. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-Q | Filing | Aug 14, 2026 | Jun 30, 2026 |
| EFFECT | Filing | Apr 28, 2026 | — |
| EFFECT | Filing | Feb 11, 2026 | — |
| CORRESP | Letter to the SEC | Feb 10, 2026 | — |
| DRS | Filing | Dec 19, 2025 | — |
| EFFECT | Filing | Dec 10, 2025 | — |
| CORRESP | Letter to the SEC | Dec 8, 2025 | — |
| D | Filing | Oct 9, 2025 | — |
| NT 10-Q | March 31, 2024 | May 16, 2024 | Mar 31, 2024 |
| EFFECT | Filing | Apr 18, 2024 | — |
| CORRESP | Letter to the SEC | Apr 17, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 11, 2024 | — |
| EFFECT | Filing | Feb 14, 2023 | — |
| CORRESP | Letter to the SEC | Feb 13, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 10, 2023 | — |
| EFFECT | Filing | Oct 4, 2022 | — |
| EFFECT | Filing | Jun 16, 2022 | — |
| CORRESP | Letter to the SEC | Jun 13, 2022 | — |
| UPLOAD | Letter from the SEC | May 20, 2022 | — |
| RW | Requestforwithdrawal | Nov 23, 2021 | — |
| EFFECT | Filing | Nov 4, 2021 | — |
| CERT | Filing | Nov 4, 2021 | — |
| 8-A12B | Registration of common stock | Nov 4, 2021 | — |
| CORRESP | Letter to the SEC | Nov 4, 2021 | — |
| CORRESP | Letter to the SEC | Nov 4, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2021 | — |
| NT 10-K | Biorestorative therapies, inc. form 12b-25 10-k 2020 | Apr 1, 2021 | Dec 31, 2020 |
| NT 10-K | Form 12b-25 for period ended december 31, 2019 | Mar 31, 2020 | Dec 31, 2019 |
| RW | S-1 withdrawal | Sep 21, 2018 | — |
| D/A | Filing | May 9, 2016 | — |
| D/A | Filing | Nov 25, 2015 | — |
| NT 10-Q | 12b-25 10-q september 30, 2015 | Nov 17, 2015 | Sep 30, 2015 |
| EFFECT | Filing | Nov 9, 2015 | — |
| CORRESP | Letter to the SEC | Nov 9, 2015 | — |
| CORRESP | Letter to the SEC | Oct 28, 2015 | — |
| CORRESP | Letter to the SEC | Oct 28, 2015 | — |
| CORRESP | Letter to the SEC | Oct 26, 2015 | — |
| CORRESP | Letter to the SEC | Oct 26, 2015 | — |
| 8-A12B | Biorestorative therapies, inc. form8-a 12b | Oct 20, 2015 | — |
| CORRESP | Letter to the SEC | Oct 20, 2015 | — |
| CORRESP | Letter to the SEC | Oct 20, 2015 | — |
| UPLOAD | Letter from the SEC | Jun 10, 2015 | — |
| CT ORDER | Filing | Mar 19, 2015 | — |
| D/A | Filing | Jan 13, 2015 | — |
| CT ORDER | Filing | Jul 14, 2014 | — |
| NT 10-K | Brt 12b-25 - y/e 2013 | Apr 1, 2014 | Dec 31, 2013 |
| D/A | Filing | Mar 26, 2014 | — |
| D | Filing | Mar 20, 2014 | — |
| D | Filing | Dec 17, 2013 | — |
| NT 10-Q | Brt form 12b-25 for period september 30, 2013 | Nov 15, 2013 | Sep 30, 2013 |
| NT 10-Q | Biorestorative therapies 12b-25 for june 30, 2013 | Aug 14, 2013 | Jun 30, 2013 |
| NT 10-K | Form 12b-25 | Apr 2, 2013 | Dec 31, 2012 |
| UPLOAD | Letter from the SEC | Oct 19, 2012 | — |
| PRER14A | Brt proxy statement revised no. 1 | Oct 18, 2012 | — |
| CORRESP | Letter to the SEC | Oct 18, 2012 | — |
| UPLOAD | Letter from the SEC | Oct 16, 2012 | — |
| D | Filing | Apr 18, 2012 | — |
| NT 10-K | Brt 12b25 for y/e 12/31/12 | Apr 2, 2012 | Dec 31, 2011 |
| UPLOAD | Letter from the SEC | Nov 23, 2011 | — |
| NT 10-Q | 12b-25 for september 30, 2011 10-q | Nov 15, 2011 | Nov 15, 2011 |
| 10-12G/A | Brt form 10 amendment no. 3 | Nov 14, 2011 | — |
| CORRESP | Letter to the SEC | Nov 14, 2011 | — |
| UPLOAD | Letter from the SEC | Oct 6, 2011 | — |
| 10-12G/A | Form 10/amendment no. 2 | Sep 6, 2011 | — |
| CORRESP | Letter to the SEC | Sep 6, 2011 | — |
| CORRESP | Letter to the SEC | Aug 26, 2011 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2011 | — |
| 10-12G/A | Sca form 10/amendment no. 1 | Jul 11, 2011 | — |
| CORRESP | Letter to the SEC | Jul 8, 2011 | — |
| UPLOAD | Letter from the SEC | Jun 6, 2011 | — |
| 10-12G | Form 10 to stem cell assurance, inc. | May 12, 2011 | — |
| D/A | Filing | Mar 9, 2011 | — |
| D | Filing | Nov 16, 2010 | — |
Showing 73 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Misc Health & Allied Services, NEC (SIC 8090)
- Listed as
- BRTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Melville, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1505497
- Former names
- Stem Cell Assurance, Inc. (until Aug 16, 2011)
Other Services-Misc Health & Allied Services, NEC companies
- Fresenius Medical Care AG FMS
- Davita Inc. DVA
- Sotera Health Co SHC
- Progyny, Inc. PGNY
- agilon health, inc. AGL
- Charming Medical Ltd MCTA
- Viemed Healthcare, Inc. VMD
- Park Dental Partners, Inc. PARK
All 15 Services-Misc Health & Allied Services, NEC companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.